These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 22592083)

  • 1. Platelet usage trends in a tertiary care hospital - Could it be less and less expensive?
    Belen FB; Okur A; Kulali F; Egritas O; Kocak U; Kaya Z; Altuntas N; Yenicesu I
    Transfus Apher Sci; 2012 Aug; 47(1):101-6. PubMed ID: 22592083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of platelet transfusion triggers in a tertiary-care hospital.
    Cameron B; Rock G; Olberg B; Neurath D
    Transfusion; 2007 Feb; 47(2):206-11. PubMed ID: 17302765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto.
    Rebulla P; Finazzi G; Marangoni F; Avvisati G; Gugliotta L; Tognoni G; Barbui T; Mandelli F; Sirchia G
    N Engl J Med; 1997 Dec; 337(26):1870-5. PubMed ID: 9407153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. POLYMORPHISM OF COLLECTION, TRANSFUSION AND EFFECTIVENESS OF DONOR PLATELETS CONCENTRATES.
    Gubanova MN; Ayupova RF; Zhiburt EB
    Anesteziol Reanimatol; 2017 Jan; 62(1):77-79. PubMed ID: 29932588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utilization of platelet transfusions in the intensive care unit: indications, transfusion triggers, and platelet count responses.
    Arnold DM; Crowther MA; Cook RJ; Sigouin C; Heddle NM; Molnar L; Cook DJ
    Transfusion; 2006 Aug; 46(8):1286-91. PubMed ID: 16934061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of platelets in transfusion medicine.
    Brubaker DB
    J Am Osteopath Assoc; 1989 Dec; 89(12):1553-9. PubMed ID: 2621122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of prophylactic transfusions using single donor apheresis platelets versus pooled platelet concentrates in AML/MDS patients receiving allogeneic hematopoietic stem cell transplantation.
    Gurkan E; Patah PA; Saliba RM; Ramos CA; Anderson BS; Champlin R; de Lima M; Lichtiger B
    Bone Marrow Transplant; 2007 Sep; 40(5):461-4. PubMed ID: 17589530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An audit of platelet transfusion within the Wellington Cancer Centre.
    Buhrkuhl DC; Karlsson MK; Carter JM
    Intern Med J; 2012 Jan; 42(1):65-70. PubMed ID: 21040321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Indications for transfusions of labile blood products].
    Wautier JL
    Transfus Clin Biol; 2005 Feb; 12(1):56-8. PubMed ID: 15814294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of high-yield thrombocytapheresis on the quality of platelet products.
    Julmy F; Ammann RA; Mansouri Taleghani B; Fontana S; Hirt A; Leibundgut K
    Transfusion; 2008 Mar; 48(3):442-50. PubMed ID: 18067508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombocytopenia and bleeding in pediatric oncology patients.
    Bercovitz RS; Josephson CD
    Hematology Am Soc Hematol Educ Program; 2012; 2012():499-505. PubMed ID: 23233625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal preprocedural platelet transfusion threshold for central venous catheter insertions in patients with thrombocytopenia.
    Zeidler K; Arn K; Senn O; Schanz U; Stussi G
    Transfusion; 2011 Nov; 51(11):2269-76. PubMed ID: 21517892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelets photochemically treated with amotosalen HCl and ultraviolet A light correct prolonged bleeding times in patients with thrombocytopenia.
    Slichter SJ; Raife TJ; Davis K; Rheinschmidt M; Buchholz DH; Corash L; Conlan MG
    Transfusion; 2006 May; 46(5):731-40. PubMed ID: 16686840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe Thrombocytopenia in the NICU.
    Baer VL; Lambert DK; Henry E; Christensen RD
    Pediatrics; 2009 Dec; 124(6):e1095-100. PubMed ID: 19917581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased platelet reactivity identified by whole blood flow cytometry in Fanconi anaemia patients.
    Holzhauer S; Sitaru AG; Ebell W; Schindler D; Hanenberg H; Wirbelauer J; Walter U; Grossmann R
    Thromb Haemost; 2007 Dec; 98(6):1291-7. PubMed ID: 18064327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Very high users of platelet transfusions in the neonatal intensive care unit.
    Dohner ML; Wiedmeier SE; Stoddard RA; Null D; Lambert DK; Burnett J; Baer VL; Hunt JC; Henry E; Christensen RD
    Transfusion; 2009 May; 49(5):869-72. PubMed ID: 19175546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interventions to reduce platelet prophylactic transfusions in patients with hypoproliferative thrombocytopenia: providing patients with the full benefit.
    Vamvakas EC; Hitzler WE
    Clin Lab; 2013; 59(5-6):459-64. PubMed ID: 23865342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A therapeutic platelet transfusion strategy is safe and feasible in patients after autologous peripheral blood stem cell transplantation.
    Wandt H; Schaefer-Eckart K; Frank M; Birkmann J; Wilhelm M
    Bone Marrow Transplant; 2006 Feb; 37(4):387-92. PubMed ID: 16400342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimizing platelet transfusion therapy.
    Heal JM; Blumberg N
    Blood Rev; 2004 Sep; 18(3):149-65. PubMed ID: 15183900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet transfusion goals in oncology patients.
    Fasano RM; Josephson CD
    Hematology Am Soc Hematol Educ Program; 2015; 2015():462-70. PubMed ID: 26637759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.